Wire · opportunities
MedTech Regulator publishes 2030 Strategy to modernise patient-centred regulation for AI ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 15 October 2026 · Fusion42 review
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has published its 2030 Strategy focused on modernising patient-centred regulation for AI, digital MedTech, and personalised medicines. The strategy commits to enhancing real-world evidence use, accelerating clinical trial assessments, increasing diversity in clinical studies, cracking down on illegal medicines, and supporting life sciences innovation including AI application in regulatory processes.
This Wire brief sits within Fusion42's coverage of Medtech, and 4 sources have reported it between 6 Oct 2026 and 15 Oct 2026.
◆ ◆ The Wire takeaway
Regulation in UK medtech is speeding up and becoming more inclusive and AI-driven. You must prepare to leverage faster trial approvals and real-world data insights while navigating stricter illegal medicine enforcement.
◆ Coverage
4 sources · first reported 6 Oct 2026 · latest 15 Oct 2026
◆ Related on Wire
◆ Topics